Griffith University: Global Collaboration to Combat Chronic Lung Infection
April 10, 2024
April 10, 2024
GOLD COAST, Australia, April 10 (TNSres) -- Griffith University issued the following news:
Scientists have discovered a target for the development of a drug to combat a bacterium that can cause chronic lung infection in hospitalised patients, immunocompromised individuals and people with cystic fibrosis.
The multidrug-resistant bacteria Pseudomonas aeruginosa infects the lung and promotes an accelerated decline of pulmonary function. It has been acknowledged as a seriou . . .
Scientists have discovered a target for the development of a drug to combat a bacterium that can cause chronic lung infection in hospitalised patients, immunocompromised individuals and people with cystic fibrosis.
The multidrug-resistant bacteria Pseudomonas aeruginosa infects the lung and promotes an accelerated decline of pulmonary function. It has been acknowledged as a seriou . . .